GeneDx Holdings Corp.
WGS
$70.69
-$4.81-6.37%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 117.29M | 113.52M | 99.82M | 85.76M | 94.20M |
| Total Other Revenue | 3.70M | 3.22M | 2.87M | 1.36M | 1.44M |
| Total Revenue | 120.99M | 116.74M | 102.69M | 87.12M | 95.64M |
| Cost of Revenue | 36.72M | 32.22M | 31.79M | 28.64M | 29.44M |
| Gross Profit | 84.27M | 84.53M | 70.90M | 58.48M | 66.21M |
| SG&A Expenses | 72.56M | 67.95M | 46.86M | 50.45M | 45.81M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 133.82M | 119.99M | 93.73M | 91.67M | 86.83M |
| Operating Income | -12.83M | -3.25M | 8.96M | -4.55M | 8.81M |
| Income Before Tax | -18.23M | -7.39M | 10.56M | -6.08M | 5.41M |
| Income Tax Expenses | -564.00K | 247.00K | -246.00K | 447.00K | -24.00K |
| Earnings from Continuing Operations | -17.67M | -7.64M | 10.81M | -6.53M | 5.44M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -17.67M | -7.64M | 10.81M | -6.53M | 5.44M |
| EBIT | -12.83M | -3.25M | 8.96M | -4.55M | 8.81M |
| EBITDA | -6.85M | 3.22M | 15.15M | 1.13M | 13.46M |
| EPS Basic | -0.61 | -0.27 | 0.38 | -0.23 | 0.20 |
| Normalized Basic EPS | -0.34 | -0.11 | 0.25 | -0.14 | 0.41 |
| EPS Diluted | -0.61 | -0.27 | 0.36 | -0.23 | 0.20 |
| Normalized Diluted EPS | -0.34 | -0.11 | 0.24 | -0.14 | 0.41 |
| Average Basic Shares Outstanding | 29.05M | 28.80M | 28.58M | 28.15M | 27.78M |
| Average Diluted Shares Outstanding | 29.05M | 28.80M | 29.75M | 28.15M | 27.78M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |